Merz Therapeutics Closes $185M Asset Purchase Agreement with Acorda Therapeutics
Acquisition of INBRIJA (levodopa inhalation powder) and (F)AMPYRA (fampridine) expands specialty neurology portfolio Lays groundwork for Parkinson’s disease franchise and anchor in multiple sclerosis therapy Plans include growth of U.S. workforce by more than





